drugset / Trial / NCT00320723

Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia

NCT00320723

Phase 4 Completed 100 enrolled North Suffolk Mental Health Association
RandomizedParallel-groupDouble-blindTreatment

Summary

This proposal seeks to evaluate a pilot smoking cessation treatment program that will combine nicotine replacement therapy with or without bupropion sustained-release (SR) with cognitive behavioral therapy for smoking cessation in patients with major mental illness.

Timeline

Start
2001-07
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule
Subject Nicotine Unknown Other